The routine, twice-weekly asymptomatic Covid-19 testing by pharmacy staff can be paused from the end of August.
The health regulator announced that regular asymptomatic testing for Covid-19 will be paused in all remaining health and care settings from 31 August 2022.
Currently all pharmacy staff test twice-weekly for Covid-19, using a self-administered Lateral Flow Device (LFD) test at home.
"Prevalence of Covid-19 in the community has fallen and remains at a comparatively low level as we emerge from the current Omicron wave. This means that the
likelihood that individuals entering healthcare settings are infectious has also reduced and the relative risk of onward transmission into these settings is lower."
The Belly Buster challenge will get you ready for this summer vacation. Lose belly fat with a 30-day Abdominal exercise plan including belly busting tips, 4 Saturday weekend warrior classes & a weekly weigh-in to keep you on track. Visit Save Local Now and find out the best offer matching your requirements for all your health and fitness needs in Clintonville, 54929 WI area.
We use meditation practices weekly in speech therapy with my clients that stutter. Guided meditation is a great way to start. Contact today for more information 800-376-3440
What is The 21 Day Flat Belly Fix Recipe?
Using the simplest words possible, the flat belly fix program is a weight loss manual by Todd Lamb intended to set you on the right path to eliminating your stubborn belly fat without starving yourself or doing any exercise more strenuous than walking to the fridge.
The flat belly fix diet book focuses on a simple to follow step-by-step guides to help almost anyone naturally get rid of their excess belly fat rather than the heavy workout, weight loss pills and surgical approach that are expensive and not a safe way to lose body fat.
The flat belly fix is not just a pack of diet plans that will help you shed excess body fat, it includes interesting and easy to carry out workout plans, and it is accompanied with weekly one-on-one ...click link for more
A news report suggests the Department of Health and Social Care is aiming to be ready to start charging for Covid-19 tests which are currently free at the end of June.
Britain has been increasingly dependent on rapid testing to try to tackle the more-transmissible Omicron variant, which has spread rapidly through the population but is less severe.
The government has previously said it will end the universal free provision of easy-to-use lateral flow devices (LFDs) at a "later stage", with individuals and businesses bearing the cost.
The Department of Health has declined to say what the tests cost, citing commercial contracts. One source has told the Reuters news agency they can run to £30 for a pack of seven.
Free pick up from pharmacies
The tests have been made freely available to order online or pick up from local pharmacies since April. The UK Health Security Agency said that between December 30 and January 5 more than 8 million LFDs were conducted, the highest weekly figure on record.
Throughout our lifetime, at some time or another, we can all find ourselves carrying a few extra unwanted pounds! Let's face it, in this day and age gaining
weight can be incredibly easy, sometimes all it takes is a break within our willpower, that leads us to give in to temptation! It can happen on our weekly shopping
trip, the moment we try our utmost to dodge that sweet however extremely inviting snack aisle, to then suddenly find ourselves failing immensely due to our
ever-hungry sweet tooth taking control. We can be sat in front of the TV at home watching our favorite show to then be cursed with the next advert, showcasing the
release of the next unhealthy, however extremely delicious sugary creation or we could be on our way to work fuelled on an empty stomach to find our full attention
stolen by the latest billboard advertising the next invention in the fast-food chain! Yes, it can be ever so easy to give in to the mouthwatering temptations the
world has to offer!
Weight loss drug Wegovy has transformed the obesity market and pharmaceutical companies with existing treatments are hoping the resulting demand will boost
demand for their older, less effective but cheaper, drugs.
A weekly injection of Wegovy, which was launched in the U.S. in June 2021, leads to an average weight loss of around 15%, alongside changes to diet and exercise.
Its impact has captured the attention of patients, investors and even celebrities.
But supply issues for Wegovy manufacturer Novo Nordisk means the Danish drugmaker has struggled to meet surging U.S. demand, delaying a launch in most of Europe.
Insurers and some national governments have also baulked at its cost, while a minority of patients do not respond to it.
Vivus and Currax Pharmaceuticals, U.S.-based developers whose treatments have been on the U.S. market for around a decade, hope to benefit from the attention and
supply shortage.
But scientists and investors say that lower efficacy plus side effects could continue to hold the treatments back.
Britain plans to launch a pilot programme exploring how new weekly weight-loss shots such as Novo Nordisk's Wegovy can be given to obese patients by general
practitioners even as the drug's market launch remains unclear.
The government's announcement on the £40 million pilot programme comes after drug cost-effectiveness watchdog NICE in March recommended the use of Wegovy in adults
with at least one weight-related condition and a body mass index of 35, but only within the NHS specialist weight management scheme.
The timing of Wegovy's launch in Britain - which would be only the fourth country to use it - is uncertain, however, after Novo last month rationed starter doses
to secure supply to U.S. patients already on the regimen, after it was overwhelmed by demand there.
British Prime Minister Rishi Sunak said on Wednesday (May 7) the pilot and fighting obesity-related diseases could reduce pressure on hospitals.
It would also support "people to live healthier and longer lives, and helping to deliver on my priority to cut NHS waiting lists".
The NHS endured a tough winter in England in particular, with waiting lists hitting record highs and staff striking for higher pay amid double-digit inflation.
British pharmacy chain Superdrug has announced plans to cease the sale of disposable vapes in all its UK and Ireland stores, citing the environmental impact
caused by its disposal and popularity among young people.
The pharmacy retailer will discontinue selling brands like Vuse GO and Flavaah Bars, with plans to completely clear out existing stock by the end of the year, the
company said in statement.
Superdrug, which previously sold 1,300 single-use vapes weekly, expects a potential impact on revenue stemming from this decision. The company has not yet started
selling vapes online.
"This decision was made to safeguard the environment," the company said on Sept.22, highlighting the risk of fires due to improper disposal of vapes, as many of
them contain lithium batteries.
The consequences of NHS workforce crisis is not limited to general practice, community pharmacies are also suffering, commented Community Pharmacy England
after the General Medical Council (GMC) published a report on Friday (23 June) which warned of the burnout in the workforce.
The report calls for urgent actions to break a 'vicious cycle' of unmanageable workloads, dissatisfaction and burnout that is causing UK doctors to take steps to
quit.
Chief Executive Janet Morrison, said: "The GMC's report is yet another clear signal of the scale of the mounting the NHS workforce crisis, and this is not limited
to general practice: community pharmacies are also suffering the consequences of it."
"Pharmacy teams are overstretched, feeling immense pressures, and dealing with significantly increased workloads. Pharmacy owners are also finding it impossible to
make ends meet, not least given the rising staffing costs which are being driven up by workforce issues.
Findings show the number of doctors who reported working beyond their rostered hours on a weekly basis rose from 59% in 2021 to 70% in 2022, and 42% said they felt
unable to cope with their workload each week (up from 30% in 2021). Just half said they were satisfied in their work, down from 70% in 2021.
Despite being relatively new to the dispensing doctor market as a short-liner, Bestway Medhub is seeing exponential growth in the market in addition to
the 3,500 independent pharmacies that we service and deliver to.
We have however been servicing the dispensing doctor market for well over 40 years through our dispensing appliance contractor (DAC) Wardles.
Wardles service and supply more than 55% of all dispensing sites with dressings, bandages, appliances, ostomy, wound care and hosiery.
Graham Burford-Row
To meet the needs of dispensing practices and surgeries we carry a large range of more than 10,000 Generics, PI's and OTC products. We offer net pricing so the
practice can see straight away what price they are paying for their products - with no hidden fees.
We offer all our practices 24-hour online ordering via our Bestway Medhub ordering portal and our recently launched Wardles FP Portal. Additionally, we have the
backup of a telesales department with personal service from myself and a dedicated Internal Dispensing Dr Account Manager.
We offer daily, weekly or monthly calls to those customers wishing to hear our special offers. Our deliveries are done daily via our third party full-line logistics
partner for efficient deliveries, which no other short-line wholesaler offers.
Bestway Medhub understands that dispensing practices are not only in the business of offering superior care to their patients and community, but they also offer
numerous other services like clinics, nursing and referrals. By enabling practices to cost save, the funds could be used elsewhere instead.
The UK Health Security Agency (UKHSA) and the Office for National Statistics (ONS) will jointly launch a new study to gather data on COVID-19 this winter.
The Winter COVID-19 Infection Study (WCIS) will run from November 2023 to March 2024, involving up to 200,000 participants, UKHSA has said on Monday (October 2).
UKHSA previously commissioned the Coronavirus Infection Survey (CIS), conducted by the ONS in collaboration with scientific study leaders from Oxford University,
analysing more than 11.5 million swab tests and 3 million blood tests from April 2020 to March 2023.
Meanwhile, the Winter CIS study involves conducting up to 32,000 lateral flow tests weekly, providing vital insights into COVID-19 prevalence in the broader
community. The sample will be structured to broadly reflect key population characteristics.
Winter pressures are already mounting on NHS staff ahead of December, with high levels of demand in hospitals due to a significant increase in cases of
norovirus infection.
Norovirus is a highly contagious virus which spreads through contaminated food, water or surfaces and causes vomiting and diarrhea.
New NHS figures revealed that an average of 351 people were hospitalised with diarrhoea and vomiting symptoms every day last week in England, almost triple the
number during the same period last winter, which was 126.
The number of children in hospital with the virus was also higher last week (13) compared the same week last year (an average of just three), according to the
weekly winter update published by the health service on 30 November.
Healthcare staff across England are facing increasing winter pressures amid junior doctor's strikes, as thousands of hospital beds are being occupied by
patients with flu, norovirus and Covid-19.
The number of flu patients in hospital has increased by almost two thirds in a week, according to the latest weekly update from the National health Service (NHS).
New NHS figures published on Thursday showed an average of 648 patients were hospitalised with flu per day this week before the industrial action, up from 402
last week. This lasts number is four times the figure reported at the end of last month (160 per in the week ending 26 November).
The feet allow you to get around, give you balance and support body weight when you walk or run. Keeping feet well cared for is not just a matter of vanity.
Some simple daily care can prevent diseases caused by fungi and bacteria and pain in the soles.
To ensure smooth and healthy feet, some care is essential to maintain a good appearance and comfort. Do you want to know more about it? Continue reading and
discover four efficient tips to keep your feet well cared for.
SKIN HYDRATION
WATCH YOUR NAILS
WEEKLY EXFOLIATION
FOOT HYGIENE
As you can see, maintaining daily care is essential for those who want to have well-treated feet, regardless of their age or sex. After all, they play an essential role in your health, well-being, and quality of life. Therefore, they need attention so that you can walk safely and confidently.
Please ensure you make frequent visits to a healthcare professional to check your feet for sensation and pulses at least yearly.
The Medicines and Healthcare products Regulatory Agency (MHRA) on Monday (29 January 2024) approved the medicine Rezzayo (rezafungin) to treat invasive
candidiasis, an infection caused by a yeast called Candida.
Invasive candidiasis can pose a serious health risk as it can affect the blood, heart, brain, eyes, bones and other parts of the body.
Napp Pharmaceuticals Ltd was granted the marketing authorisation for the medicine based on phase 3 clinical trial data.
In the randomised, double-blind, controlled study, more than half of the invasive candidiasis patients who were given a weekly dose of rezafungin were cured at
day 14.
Among 94 patients who were given a daily dose of caspofungin (another antifungal treatment), 57 of them were cured during the same time.